Bottom line
SCHLX vs HRTS: the short answer
SCHLX (DWS Health and Wellness Fund) and HRTS (Tema Heart & Health ETF) share a meaningful slice of their top holdings — about 64% by weight.
HRTS is cheaper at 0.75% vs 1.06% — a difference of $31 a year per $10,000 invested.
Updated Nov 19, 2026
SCHLX vs HRTS side by side
| SCHLX | HRTS | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | DWS (Xtrackers) | Innovator |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.06% | 0.75% |
| Annual cost per $10k | $106 | $75 |
| 10-yr cost on $10k (prospectus) | $1,294 | $1,168 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | — | +23.6% |
| 5-yr return (annualized) | — | — |
| 10-yr return (annualized) | — | — |
| Best quarter | — | +15.8% |
| Worst quarter | — | −12.4% |
| Net assets (fund) | $231.8M | $51.9M |
| Number of holdings | 65 | 45 |
| Portfolio turnover | 2% | 4% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
16 of SCHLX's top 25 holdings also appear in HRTS's top 25.
| Holding | SCHLX | HRTS |
|---|---|---|
| Eli Lilly & Co | 13.85% | 11.52% |
| Johnson & Johnson | 6.19% | 3.59% |
| UnitedHealth Group Inc | 5.73% | 5.24% |
| AbbVie Inc | 4.90% | 2.40% |
| Merck & Co Inc | 4.85% | 4.27% |
| AstraZeneca PLC | 3.80% | 4.00% |
| Thermo Fisher Scientific Inc | 3.46% | 3.97% |
| Amgen Inc | 2.88% | 1.91% |
| Gilead Sciences Inc | 2.78% | 3.43% |
| Vertex Pharmaceuticals Inc | 2.45% | 2.93% |
| Abbott Laboratories | 2.39% | 2.61% |
| Danaher Corp | 2.13% | 2.66% |
| McKesson Corp | 2.05% | 1.71% |
| Medtronic PLC | 1.54% | 1.88% |
| Bristol-Myers Squibb Co | 1.50% | 2.09% |
Source: SEC Form N-PORT
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
HRTS top 10
- Eli Lilly & Co — 11.52%
- UnitedHealth Group Inc — 5.24%
- Novo Nordisk A/S — 5.24%
- Roche Holding AG — 4.50%
- Merck & Co Inc — 4.27%
- AstraZeneca PLC — 4.00%
- Thermo Fisher Scientific Inc — 3.97%
- Johnson & Johnson — 3.59%
- Gilead Sciences Inc — 3.43%
- Novartis AG — 3.38%
FAQ
What is the difference between SCHLX and HRTS?
SCHLX (DWS Health and Wellness Fund) and HRTS (Tema Heart & Health ETF) share a meaningful slice of their top holdings — about 64% by weight. HRTS is cheaper at 0.75% vs 1.06% — a difference of $31 a year per $10,000 invested.
Which is cheaper, SCHLX or HRTS?
HRTS has the lower expense ratio (0.75%).
Should I own both SCHLX and HRTS?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.